These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24802331)

  • 1. Meta-analysis of molecular imaging of serotonin transporters in major depression.
    Gryglewski G; Lanzenberger R; Kranz GS; Cumming P
    J Cereb Blood Flow Metab; 2014 Jul; 34(7):1096-103. PubMed ID: 24802331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
    Bhagwagar Z; Murthy N; Selvaraj S; Hinz R; Taylor M; Fancy S; Grasby P; Cowen P
    Am J Psychiatry; 2007 Dec; 164(12):1858-65. PubMed ID: 18056241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment.
    Meyer JH
    J Psychiatry Neurosci; 2007 Mar; 32(2):86-102. PubMed ID: 17353938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
    Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A positron emission tomography study of the serotonergic system in relation to anxiety in depression.
    Iscan Z; Rakesh G; Rossano S; Yang J; Zhang M; Miller J; Sullivan GM; Sharma P; McClure M; Oquendo MA; Mann JJ; Parsey RV; DeLorenzo C
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):1011-1021. PubMed ID: 28811068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study.
    Ananth MR; DeLorenzo C; Yang J; Mann JJ; Parsey RV
    J Nucl Med; 2018 Apr; 59(4):665-670. PubMed ID: 28935838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.
    Miller JM; Oquendo MA; Ogden RT; Mann JJ; Parsey RV
    J Psychiatr Res; 2008 Oct; 42(14):1137-44. PubMed ID: 18331740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
    Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serotonin transporter in depression: Meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression.
    Kambeitz JP; Howes OD
    J Affect Disord; 2015 Nov; 186():358-66. PubMed ID: 26281039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior.
    Bartlett EA; Zanderigo F; Stanley B; Choo TH; Galfalvy HC; Pantazatos SP; Sublette ME; Miller JM; Oquendo MA; Mann JJ
    Eur Neuropsychopharmacol; 2023 May; 70():1-13. PubMed ID: 36780841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
    Kasper S; Tauscher J; Willeit M; Stamenkovic M; Neumeister A; Küfferle B; Barnas C; Stastny J; Praschak-Rieder N; Pezawas L; de Zwaan M; Quiner S; Pirker W; Asenbaum S; Podreka I; Brücke T
    World J Biol Psychiatry; 2002 Jul; 3(3):133-46. PubMed ID: 12478878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.
    Meyer JH; Wilson AA; Sagrati S; Miler L; Rusjan P; Bloomfield PM; Clark M; Sacher J; Voineskos AN; Houle S
    Arch Gen Psychiatry; 2009 Dec; 66(12):1304-12. PubMed ID: 19996035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study.
    Reimold M; Batra A; Knobel A; Smolka MN; Zimmer A; Mann K; Solbach C; Reischl G; Schwärzler F; Gründer G; Machulla HJ; Bares R; Heinz A
    Mol Psychiatry; 2008 Jun; 13(6):606-13, 557. PubMed ID: 18268503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging of the serotonin transporter availability and occupancy by antidepressant treatment in late-life depression.
    Smith GS; Kuwabara H; Gould NF; Nassery N; Savonenko A; Joo JH; Bigos KL; Kraut M; Brasic J; Holt DP; Hall AW; Mathews WB; Dannals RF; Nandi A; Workman CI
    Neuropharmacology; 2021 Aug; 194():108447. PubMed ID: 33450276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter binding in major depressive disorder: impact of serotonin system anatomy.
    Bartlett EA; Zanderigo F; Shieh D; Miller J; Hurley P; Rubin-Falcone H; Oquendo MA; Sublette ME; Ogden RT; Mann JJ
    Mol Psychiatry; 2022 Aug; 27(8):3417-3424. PubMed ID: 35487966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower serotonin transporter binding potential in the human brain during major depressive episodes.
    Parsey RV; Hastings RS; Oquendo MA; Huang YY; Simpson N; Arcement J; Huang Y; Ogden RT; Van Heertum RL; Arango V; Mann JJ
    Am J Psychiatry; 2006 Jan; 163(1):52-8. PubMed ID: 16390889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression.
    Gopaldas M; Zanderigo F; Zhan S; Ogden RT; Miller JM; Rubin-Falcone H; Cooper TB; Oquendo MA; Sullivan G; Mann JJ; Sublette ME
    J Affect Disord; 2019 Oct; 257():495-503. PubMed ID: 31319341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reported childhood abuse is associated with low serotonin transporter binding in vivo in major depressive disorder.
    Miller JM; Kinnally EL; Ogden RT; Oquendo MA; Mann JJ; Parsey RV
    Synapse; 2009 Jul; 63(7):565-73. PubMed ID: 19288578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.